Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluation of Platelet-Rich Plasma (PRP) Treatment in Tendinopathies
Sponsor: ReSport Clinic
Summary
This multicenter, prospective, observational study, based on real-world evidence (RWE), aims to evaluate the efficacy and safety of Platelet-Rich Plasma (PRP) treatment across four types of tendinopathies: patellar, Achilles, epicondylar, and plantar fasciosis. Data collection and analysis will be conducted using the BioSmartData® platform, including hematology analyzers for PRP characterization, clinical variables, treatment protocols, and longitudinal assessment of therapeutic response.
Official title: Multicenter Real-World Evidence (RWE) Study: Evaluation of Platelet-Rich Plasma (PRP) Treatment in Tendinopathies
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
2000
Start Date
2026-04
Completion Date
2028-03
Last Updated
2026-04-30
Healthy Volunteers
No
Conditions
Interventions
Platelet rich plasma (PRP)
A minimal description of the standard PRP preparation and administration protocol will be included to document clinical variability and enable comparative analyses. Across all participating centers, the following variables will be systematically recorded: Type of PRP used (leukocyte-rich vs. leukocyte-poor), with standardized coding Preparation method (single vs. double centrifugation), including specification of the device used Injected volume Anatomical site and administration technique (ultrasound-guided whenever feasible) Number of treatment sessions and interval between sessions
Locations (5)
Instituto Médico Arriaza
A Coruña, Spain
Instituto Cugat
Barcelona, Spain
ReSport Clinic
Barcelona, Spain
Ripoll y dePrado Medical Group
Madrid, Spain
Hospital MIKS
Vitoria-Gasteiz, Spain